GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Receptor Agonists

Company
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
65 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

65 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Receptor Agonists and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03158090

    The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

    Ginkgo Leaf Center for Rare Disorders 1965 participants Est. completion 2051-01-30 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Recruiting NCT NCT05311072

    Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China

    China-Japan Friendship Hospital 1500 participants Est. completion 2027-12-31 1 site
    Other conditions: Chronic Thromboembolic Pulmonary Hypertension
    View official trial listing →
  • Recruiting NCT NCT05663515

    A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

    AstraZeneca 24000 participants Est. completion 2026-10-01 8 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05931718

    Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200 participants Est. completion 2035-06 1 site
    Other conditions: Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, Chronic Idiopathic Neutropenia, Autoimmune Neutropenia, Myelodysplastic Syndromes, Cold Agglutinin Disease
    View official trial listing →
  • Recruiting NCT NCT06132477

    Impact GLP-1 Agonists Following Bariatric

    Not yet reported University of Missouri-Columbia 150 participants Est. completion 2030-07 1 site
    Metabolic syndromeObstructive sleep apnea Other conditions: Morbid Obesity, Diabetes Mellitus, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06256419

    Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 300 participants Est. completion 2028-01-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Susceptibility, Genetic
    View official trial listing →
  • Recruiting NCT NCT06324461

    GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

    Not yet reported The University of Hong Kong 372 participants Est. completion 2028-12-31 3 sites
    Other conditions: Myocardial Injury
    View official trial listing →
  • Recruiting NCT NCT06576401

    A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 10 participants Est. completion 2024-12 1 site
    Other conditions: Healthy Adult Subject
    View official trial listing →
  • Recruiting NCT NCT06582875

    Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

    Not yet reported University of Colorado, Denver 126 participants Est. completion 2029-06-30 1 site
    Other conditions: Autosomal Dominant Polycystic Kidney, Obesity
    View official trial listing →
  • Recruiting NCT NCT06613880

    Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 48 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Aplastic Anemia, TPO Receptor Agonists
    View official trial listing →
  • Recruiting NCT NCT06661174

    A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

    China-Japan Friendship Hospital 100 participants Est. completion 2025-10-30 1 site
    Chronic kidney disease Other conditions: Bariatric Surgeries
    View official trial listing →
  • Recruiting NCT NCT06734312

    MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

    Not yet reported Dr. Christopher McGowan 20 participants Est. completion 2026-06 2 sites Added to GLP-1
    Other conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight, Obesity Prevention, Obesity Recidivism, GLP-1, Ablation Techniques
    View official trial listing →
  • Recruiting NCT NCT06796361

    Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

    Not yet reported University Hospital, Basel, Switzerland 16 participants Est. completion 2026-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT06821919

    Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)

    Western Galilee Hospital-Nahariya 70 participants Est. completion 2031-12-30 1 site
    Other conditions: Diabetes Mellitus, Kidney Disease
    View official trial listing →
  • Recruiting NCT NCT06825182

    Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

    Not yet reported Nanjing First Hospital, Nanjing Medical University 1000 participants Est. completion 2025-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06839248

    Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

    Not yet reported St Vincent's Hospital Melbourne 154 participants Est. completion 2027-02-01 2 sites
    Other conditions: Residual Gastric Contents, Pulmonary Aspiration of Gastric Contents
    View official trial listing →
  • Recruiting NCT NCT06889454

    Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

    Attikon Hospital 120 participants Est. completion 2026-02-01 1 site
    Metabolic syndrome Other conditions: PCOS, Hyperinsulinism, Hyperandrogenism
    View official trial listing →
  • Recruiting NCT NCT06905054

    Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

    Not yet reported Mayo Clinic 80 participants Est. completion 2028-07-01 1 site
    Other conditions: Primary Sclerosing Cholangitis, Liver Transplant, Complications, PSC, Biliary Strictures
    View official trial listing →
  • Recruiting NCT NCT06908694

    Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

    Not yet reported Hamilton Health Sciences Corporation 20 participants Est. completion 2026-07-31 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07006142

    Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

    Not yet reported Mayo Clinic 150 participants Est. completion 2026-08-30 1 site Stand-alone
    Other conditions: Upper Endoscopy, GLP1-R-related Disease
    View official trial listing →
  • Recruiting NCT NCT07012642

    Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

    Not yet reported Advanced Reconstructive Surgery Alliance 110 participants Est. completion 2027-04-09 2 sites Stand-alone
    Other conditions: Lymphedema
    View official trial listing →
  • Recruiting NCT NCT07017270

    Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

    Not yet reported Unity Health Toronto 100 participants Est. completion 2027-09 2 sites
    Other conditions: Kidney Disease, Chronic, Diabetes, Dialysis, End Stage Kidney Disease (ESRD)
    View official trial listing →
  • Recruiting NCT NCT07027995

    Food and Fitness With Medicine (FFWM)

    Not yet reported Ohio State University 200 participants Est. completion 2029-03 4 sites
    Metabolic syndromeType 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07058155

    Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

    Not yet reported The Cleveland Clinic 70 participants Est. completion 2034-02-01 1 site
    Other conditions: Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPS
    View official trial listing →
  • Recruiting NCT NCT07075341

    Healthy Living BEYOND Weight Study

    American Heart Association 1000000 participants Est. completion 2060-12 1 site
    Other conditions: Overweight or Obesity
    View official trial listing →
  • Recruiting NCT NCT07082114

    A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 800 participants Est. completion 2027-05-17 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07111494

    Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

    Not yet reported Medical College of Wisconsin 22 participants Est. completion 2028-10-15 1 site
    Other conditions: Psoriatic Arthritis (PsA)
    View official trial listing →
  • Recruiting NCT NCT07169136

    Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

    Nemours Children's Clinic 20 participants Est. completion 2026-12 1 site
    Other conditions: Polycystic Ovarian Syndrome in Adolescent Females, Obesity (Disorder)
    View official trial listing →
  • Recruiting NCT NCT07193459

    Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360 participants Est. completion 2027-02-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07195006

    Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories

    University of Zimbabwe 368 participants Est. completion 2032-12-31 1 site
    Other conditions: Malnutrition Pregnancy, Malnutrition in Children, Malnutrition (Calorie), Environmental Enteric Dysfunction, Gut Dysbiosis, Gut Permeability, Gut Inflammation, Diarrhea Infectious, Maternal Stress, Child Mental Health, Natural Killer Cell Mediated Immunity, Mycotoxin Biomonitoring, Environmental Exposures, Cell-Mediated Immune Deficiency
    View official trial listing →
  • Recruiting NCT NCT07213323

    Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

    Not yet reported Hospices Civils de Lyon 50 participants Est. completion 2028-08-05 1 site
    Other conditions: Obesity &Amp; Overweight, Digestive Disorders
    View official trial listing →
  • Recruiting NCT NCT07221214

    GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

    Not yet reported Vanderbilt University Medical Center 200 participants Est. completion 2030-01-31 1 site
    Cardiovascular disease Other conditions: HIV, Alcohol, Smoking Cigarette
    View official trial listing →
  • Recruiting NCT NCT07224880

    Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

    Cytrellis Biosystems, Inc. 10 participants Est. completion 2026-02-28 1 site
    Other conditions: glp1 Agonist, Gene Expression, Skin Laxity
    View official trial listing →
  • Recruiting NCT NCT07229170

    Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

    San Raffaele Telematic University 150 participants Est. completion 2028-01-01 4 sites Stand-alone
    Other conditions: Obesity & Overweight, Taste Alterations, Weight Loss, Eating Behavior Changes
    View official trial listing →
  • Recruiting NCT NCT07244003

    Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430 participants Est. completion 2028-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07244445

    Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

    Not yet reported Ian J. Neeland, MD 108 participants Est. completion 2027-12 1 site
    Other conditions: Dietary Change, Obesity & Overweight, Food Acceptance
    View official trial listing →
  • Recruiting NCT NCT07244458

    Dietary Peanuts and Nutrition-Related Outcomes

    Not yet reported Ian J. Neeland, MD 64 participants Est. completion 2027-12 1 site
    Other conditions: Dietary Change, Obesity & Overweight, Food Acceptance
    View official trial listing →
  • Recruiting NCT NCT07309094

    Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

    Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 site
    Chronic kidney diseaseType 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07336862

    Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

    Not yet reported, Not yet reported China-Japan Friendship Hospital 200 participants Est. completion 2027-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07362667

    A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA

    Qianfoshan Hospital 44 participants Est. completion 2028-12-31 1 site
    Other conditions: ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA), Airway Clearance, Mucus Plug, Amphotericin B, Bronchoscope
    View official trial listing →
  • Recruiting NCT NCT07362693

    A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

    Qianfoshan Hospital 50 participants Est. completion 2028-12-31 1 site
    Other conditions: ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA), Cohort Study, Allergic Bronchopulmonary Aspergillosis, Efficacy and Safety
    View official trial listing →
  • Recruiting NCT NCT07393360

    Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

    Not yet reported Pharmanutra S.p.a. 144 participants Est. completion 2026-12 3 sites
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Recruiting NCT NCT07417813

    A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders

    Shanghai Mental Health Center 121 participants Est. completion 2026-12-31 9 sites
    Other conditions: Insomnia, Psychiatric Disorders
    View official trial listing →
  • Recruiting NCT NCT07444203

    Transformative Research in Diabetic Nephropathy 2.0

    University of Pennsylvania 200 participants Est. completion 2028-11-12 1 site
    Type 2 diabetes Other conditions: Diabetic Nephropathies, Kidney Diseases, Renal Insufficiency, Chronic
    View official trial listing →
  • Recruiting NCT NCT07484061

    Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

    Not yet reported Olistic Research Labs S.L. 40 participants Est. completion 2026-10-31 1 site
    Other conditions: Telogen Effluvium
    View official trial listing →
  • Recruiting NCT NCT07495904

    Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance

    Not yet reported Hellenic Mediterranean University 130 participants Est. completion 2029-01-30 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07558863

    Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2028-08-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT07575399

    Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

    Not yet reported Amgen 300 participants Est. completion 2028-02-28 45 sites
    Other conditions: Obesity or Overweight
    View official trial listing →
  • Recruiting NCT NCT07605572

    Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

    Attikon Hospital 100 participants Est. completion 2027-02-28 1 site
    Other conditions: Dry Eye Disease (DED), Diabete Mellitus, GLP-1, Ocular Surface, Diabetes Type 2, Cornea
    View official trial listing →
  • Recruiting NCT NCT07612319

    Romiplostim for Oral TPO-RA Resistant ITP

    Not yet reported The First Affiliated Hospital of Soochow University 60 participants Est. completion 2028-06 1 site
    Other conditions: Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
    View official trial listing →
  • Recruiting NCT NCT07614230

    SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

    Not yet reported Junjie Yang 144 participants Est. completion 2028-12-31 2 sites Stand-alone
    Type 2 diabetesCardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT07619989

    Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 24 participants Est. completion 2027-09-01 1 site
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Recruiting NCT NCT07633639

    GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

    Not yet reported China-Japan Friendship Hospital 200 participants Est. completion 2028-05-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07653412

    Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

    National and Kapodistrian University of Athens 220 participants Est. completion 2027-06-30 1 site
    Other conditions: Obesity (Disorder), Anti-obesity Agents, Precision Medicine
    View official trial listing →
  • Recruiting NCT NCT07674290

    Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

    Not yet reported Tom Hühne 200 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Bardet Biedl Syndrome (BBS), Bardet Biedl Syndrome, Bardet-Biedl Syndrome (BBS), Alstrom Syndrome
    View official trial listing →
  • Recruiting NCT NCT07702461

    Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

    Ohio State University 300 participants Est. completion 2027-01 1 site
    Other conditions: Obesity & Overweight, Diabetes (DM)
    View official trial listing →
  • Recruiting NCT NCT07703683

    Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100 participants Est. completion 2056-12-31 1 site
    Other conditions: Diabetes, Obesity & Overweight, Cushing Syndrome, Metabolic Diseases, Endocrine Diseases, Sarcopenia, Sarcopenic Obesity
    View official trial listing →
  • Recruiting NCT NCT07720414

    Effects of GLP-1 RAs on Human Lactation Outcomes

    University of Colorado, Denver 18 participants Est. completion 2028-06 1 site
    Other conditions: Lactation, Weight Loss
    View official trial listing →
  • Recruiting NCT NCT07732426

    Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2028-06-30 1 site
    Other conditions: Food Addiction Tendency, Obesity, Overweight
    View official trial listing →
  • Recruiting NCT NCT07732738

    Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

    Not yet reported China-Japan Friendship Hospital 400 participants Est. completion 2027-12-30 7 sites
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07736911

    Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

    Not yet reported Fu Jen Catholic University Hospital 140 participants Est. completion 2030-06 1 site
    Other conditions: GLP-1
    View official trial listing →
  • Recruiting NCT NCT07736963

    Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

    Not yet reported Fu Jen Catholic University Hospital 240 participants Est. completion 2028-06-01 1 site
    Other conditions: GLP-1
    View official trial listing →
  • Recruiting NCT NCT07740291

    Tirzepatide Impact Assessment Study

    Not yet reported Texas Tech University 27 participants Est. completion 2026-12-07 1 site Added to GLP-1
    Other conditions: Obesity & Overweight, Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health
    View official trial listing →
  • Recruiting NCT NCT07779343

    OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

    Not yet reported University of Health Sciences, Algeria 300 participants Est. completion 2028-01-23 1 site
    Type 2 diabetes Other conditions: Obesity Difficult Airway Airway Management, Obesity Adult Onset, Obesity and Cardiovascular Risk
    View official trial listing →
  • Recruiting NCT NCT07803185

    Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

    TC Erciyes University 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Obesity, Emotional Eating, Anhedonia
    View official trial listing →
  • Withdrawn NCT NCT00210977

    A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies

    Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2010-01
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00995839

    Terlipressin in Septic Shock: Effects on Microcirculation

    Not yet reported, Not yet reported University of Roma La Sapienza 60 participants Est. completion 2010-02 1 site
    Other conditions: Septic Shock, Sepsis
    View official trial listing →
  • Completed NCT NCT01204684

    Dendritic Cell Vaccine for Patients With Brain Tumors

    Not yet reported Jonsson Comprehensive Cancer Center 24 participants Est. completion 2024-08-21 1 site
    Other conditions: Glioma, Anaplastic Astrocytoma, Anaplastic Astro-oligodendroglioma, Glioblastoma
    View official trial listing →
  • Completed NCT NCT01566890

    Microvascular Blood Flow in Sickle Cell Anemia

    Not yet reported Versiti Blood Health 91 participants Est. completion 2020-11-16 2 sites
    Other conditions: Sickle Cell Disease, Sickle Cell Anemia
    View official trial listing →
  • Status unknown NCT NCT01568125

    Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus

    Nagaoka Red Cross Hospital 100 participants Est. completion 2014-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01585350

    A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients

    Not yet reported Craig L Slingluff, Jr 53 participants Est. completion 2014-10 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01621204

    A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

    Not yet reported McMaster University 74 participants Est. completion 2019-08 10 sites Stand-alone
    Other conditions: Immune Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT01676987

    Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

    Not yet reported Ache Laboratorios Farmaceuticos S.A. 181 participants Est. completion 2011-06
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01737580

    Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

    Not yet reported University of British Columbia 59 participants Est. completion 2013-06 1 site
    Other conditions: Influenza Vaccination in Seniors
    View official trial listing →
  • Completed NCT NCT01744236

    SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

    Not yet reported Amsterdam UMC, location VUmc 70 participants Est. completion 2015-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01767389

    Glucagon-like Peptide (GLP) Utilization and Safety

    GlaxoSmithKline 1 participants Est. completion 2013-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01783470

    Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue

    Not yet reported Aaron Cypess 15 participants Est. completion 2014-10 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01788631

    A Phase II Trial of Regadenoson in Sickle Cell Anemia

    Not yet reported Dana-Farber Cancer Institute 100 participants Est. completion 2016-12-12 12 sites
    Other conditions: Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT01876433

    Beta 3 Agonist Treatment in Heart Failure

    Not yet reported Henning Bundgaard 70 participants Est. completion 2015-09-30 3 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01876719

    AR08 for Treatment of ADHD in Children

    Not yet reported Arbor Pharmaceuticals, Inc. 122 participants Est. completion 2015-02 13 sites
    Other conditions: ADHD
    View official trial listing →
  • Withdrawn NCT NCT02015780

    Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

    Not yet reported Takeda Est. completion 2016-01 30 sites Stand-alone
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Terminated NCT NCT02029846

    Glycemia in Diabetic Elders Trial

    Not yet reported Johns Hopkins University 2 participants Est. completion 2017-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02072096

    A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Eli Lilly and Company 192 participants Est. completion 2015-10 34 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02082496

    GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

    Not yet reported University of Copenhagen 50 participants Est. completion 2019-04 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02147925

    Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

    Not yet reported Sun Yat-sen University 75 participants Est. completion 2017-04 1 site
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT02150694

    Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo

    Not yet reported University of Cambridge 52 participants Est. completion 2013-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02291874

    Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Astellas Pharma Inc 100 participants Est. completion 2016-07-07 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02298075

    Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

    Gruppo Italiano Malattie EMatologiche dell'Adulto 148 participants Est. completion 2019-04-17 13 sites
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT02446834

    Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

    Not yet reported RenJi Hospital 40 participants Est. completion 2018-04 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT02456428

    Incretin-based Drugs and the Risk of Heart Failure

    Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT02472717

    Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

    Not yet reported University Health Network, Toronto Est. completion 2016-10 1 site
    PrediabetesType 2 diabetes Other conditions: Psoriatic Arthritis, Psoriasis
    View official trial listing →
  • Completed NCT NCT02475499

    Incretin-based Drugs and Pancreatic Cancer

    Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02476760

    Incretin-based Drugs and Acute Pancreatitis

    Canadian Network for Observational Drug Effect Studies, CNODES 1417914 participants Est. completion 2015-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02501850

    The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2015-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02529202

    Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia

    Not yet reported Seattle Children's Hospital 7 participants Est. completion 2017-01 1 site
    Other conditions: Hypoxic-ischemic Encephalopathy
    View official trial listing →
  • Completed NCT NCT02560324

    Effect of Ramelteon on Smoking Abstinence

    Not yet reported University of Pennsylvania 140 participants Est. completion 2018-08 1 site
    Other conditions: Tobacco Use Disorder
    View official trial listing →
  • Status unknown NCT NCT02759926

    The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake

    Not yet reported Universitaire Ziekenhuizen KU Leuven 98 participants
    Other conditions: Healthy, Obesity
    View official trial listing →
  • Status unknown NCT NCT02854904

    Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion

    Not yet reported, Not yet reported Sarah Network of Rehabilitation Hospitals 46 participants Est. completion 2017-06 1 site
    Other conditions: Spine; Arthrosis, Spondylolysis, Spondylolysis, Multiple Sites in Spine, Spondylolisthesis
    View official trial listing →
  • Completed NCT NCT02862886

    Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathways Implicated in Remodelling of the Uteroplacental Space: Experimental in Vitro Approach on Myometrial Tissue Explants

    Not yet reported Centre Hospitalier Universitaire Dijon 55 participants 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Status unknown NCT NCT02877212

    Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

    Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75 participants Est. completion 2017-09 1 site
    Other conditions: Immune Thrombocytopenic Purpura (ITP)
    View official trial listing →
  • Status unknown NCT NCT02887625

    Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

    Not yet reported Dr. Muhammad Abdulghani 410 participants Est. completion 2017-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03049462

    The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 55 participants Est. completion 2026-08-26 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT03119974

    Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

    Not yet reported Assistance Publique - Hôpitaux de Paris 48 participants Est. completion 2021-02-16 1 site
    Other conditions: Persistent or Chronic ITP
    View official trial listing →
  • Completed NCT NCT03131375

    Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia

    Not yet reported, Not yet reported Athens General Children's Hospital "Pan. & Aglaia Kyriakou" 60 participants Est. completion 2017-07-30 1 site
    Other conditions: Emergence Delirium, Extubation Time, Heart Rate, Postoperative Analgesia, Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT03135795

    The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil

    Not yet reported Huazhong University of Science and Technology 100 participants Est. completion 2017-05-31 1 site
    Other conditions: Epigenetics
    View official trial listing →
  • Completed NCT NCT03172975

    Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

    Not yet reported Baylor College of Medicine 39 participants Est. completion 2025-01-30 1 site
    Other conditions: Hookworm Infections
    View official trial listing →
  • Completed NCT NCT03341013

    A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

    Not yet reported MedImmune LLC 24 participants Est. completion 2018-01-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03396588

    Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain

    Not yet reported Henrietta Bada 120 participants Est. completion 2024-04-10 1 site
    Other conditions: Neonatal Abstinence Syndrome
    View official trial listing →
  • Completed NCT NCT03432091

    Melatonin Receptor Agonist and Peripheral Biological Markers

    National Science and Technology Council, Taiwan 40 participants Est. completion 2019-07-31
    Other conditions: Insomnia
    View official trial listing →
  • Completed NCT NCT03496207

    A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

    Not yet reported Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 106 participants Est. completion 2022-03-09 43 sites Stand-alone
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT03498001

    Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

    Not yet reported Centre Hospitalier Universitaire Dijon 42 participants Est. completion 2023-12-20 1 site
    Other conditions: Type II Diabetes
    View official trial listing →
  • Completed NCT NCT03551067

    Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

    Not yet reported Suez Canal University 74 participants Est. completion 2018-01-05 1 site
    Other conditions: Adenotonsillectomy
    View official trial listing →
  • Completed NCT NCT03712098

    Daily Liraglutide for Nicotine Dependence

    Not yet reported Rebecca Ashare 40 participants Est. completion 2022-05-25 1 site
    Other conditions: Smoking Cessation, Weight, Body
    View official trial listing →
  • Status unknown NCT NCT03774095

    Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

    Not yet reported Karina Vejrum Sørensen 10 participants Est. completion 2018-12-30 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03817931

    Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

    Not yet reported Baylor Research Institute 12 participants Est. completion 2022-02-26 2 sites
    Other conditions: Overactive Bladder, Dementia, Lower Urinary Tract Symptoms, Incontinence, Urge
    View official trial listing →
  • Completed NCT NCT03918616

    P2X7 Receptor, Inflammation and Neurodegenerative Diseases

    University of Pisa 50 participants Est. completion 2019-03-30 1 site
    Other conditions: Neuro-Degenerative Disease
    View official trial listing →
  • Completed NCT NCT03934710

    Mood Effects of Serotonin Agonists Extended

    Not yet reported University of Chicago 56 participants Est. completion 2021-06-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03937713

    Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD

    Not yet reported VA Office of Research and Development 53 participants Est. completion 2025-03-30 1 site Stand-alone
    Other conditions: Complex Insomnia
    View official trial listing →
  • Status unknown NCT NCT03959865

    GLP-1 REceptor Agonists and Real World EvIdeNce

    University of Padova 6000 participants Est. completion 2019-05-31 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03993132

    A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

    Boehringer Ingelheim 26774 participants Est. completion 2022-06-16 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03994549

    A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

    Not yet reported Zealand Pharma 64 participants Est. completion 2020-11-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04017221

    Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

    Canadian Network for Observational Drug Effect Studies, CNODES 1249636 participants Est. completion 2019-12-01 1 site
    Type 2 diabetes Other conditions: Urosepsis, Diabetic Ketoacidosis, Lower Extremity Amputation
    View official trial listing →
  • Active, not recruiting NCT NCT04019197

    Effects of Semaglutide in HIV-Associated Lipohypertrophy

    Not yet reported Case Western Reserve University 108 participants Est. completion 2026-09-01 2 sites
    Other conditions: HIV/AIDS, Lipohypertrophy, Obesity
    View official trial listing →
  • Status unknown NCT NCT04034524

    Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

    Brigham and Women's Hospital 20000 participants Est. completion 2020-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04184947

    Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

    University of Padova 10000 participants Est. completion 2020-02-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04295005

    A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

    Boehringer Ingelheim 24500 participants Est. completion 2021-09-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04295109

    Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 105 participants Est. completion 2020-07-31 1 site Stand-alone
    Other conditions: Cervix Neoplasms, Endometrial Cancer, Adenomyosis, Fibroid Uterus
    View official trial listing →
  • Status unknown NCT NCT04553536

    Cardiovascular Protection Conservative Effects of Esketamine Versus µ-opioid Receptor Agonists in General Anesthesia

    Not yet reported Second Hospital of Shanxi Medical University 1000 participants Est. completion 2024-01-31 1 site
    Other conditions: Opioid Analgesic Adverse Reaction
    View official trial listing →
  • Completed NCT NCT04878510

    Non-invasive Ventilation and Dex in Critically Ill Adults

    Not yet reported St. Joseph's Healthcare Hamilton 24 participants Est. completion 2024-04-21 3 sites Stand-alone
    Other conditions: Respiratory Insufficiency
    View official trial listing →
  • Status unknown NCT NCT04915482

    TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 94 participants Est. completion 2025-02-28 1 site
    Other conditions: Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome, Connective Tissue Diseases
    View official trial listing →
  • Completed NCT NCT04943042

    An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

    Swedish Orphan Biovitrum 199 participants Est. completion 2025-06-10 55 sites
    Other conditions: Immune Thrombocytopenia, ITP
    View official trial listing →
  • Terminated NCT NCT04964388

    Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

    Not yet reported University of Mississippi Medical Center 5 participants Est. completion 2023-07-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT05029050

    Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery

    Not yet reported Oslo University Hospital 900 participants Est. completion 2025-01 5 sites
    Other conditions: Delirium, Cognitive Decline, Frailty
    View official trial listing →
  • Completed NCT NCT05037045

    Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 338 participants Est. completion 2024-01-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05073692

    Comparison of Type 2 Diabetes Pharmacotherapy Regimens

    Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT05136287

    SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

    Jose Seijas Amigo 140 participants Est. completion 2024-01-01 11 sites
    Type 2 diabetes Other conditions: Weight Loss, Quality of Life, Safety Issues
    View official trial listing →
  • Status unknown NCT NCT05161429

    BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

    Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05215158

    Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults

    Not yet reported Aswan University Hospital 46 participants Est. completion 2023-09-15 2 sites
    Other conditions: Squint
    View official trial listing →
  • Completed NCT NCT05220878

    Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

    Not yet reported AO GENERIUM 160 participants Est. completion 2023-10-19 18 sites
    Other conditions: Idiopathic Thrombocytopenic Purpura
    View official trial listing →
  • Status unknown NCT NCT05240456

    Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children

    Not yet reported, Not yet reported Mansoura University 70 participants Est. completion 2022-12
    Other conditions: Voiding Disorders, Overactive Bladder
    View official trial listing →
  • Status unknown NCT NCT05311930

    Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69 participants Est. completion 2024-12-30
    Other conditions: Primary Immune Thrombocytopenia
    View official trial listing →
  • Active, not recruiting NCT NCT05333003

    Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

    Not yet reported Centre for Addiction and Mental Health 92 participants Est. completion 2026-08 1 site
    Other conditions: Schizophrenia Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT05466201

    The Use of Eltrombopag Post HSCT in BMFD

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 118 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Stem Cell Transplant Complications
    View official trial listing →
  • Status unknown NCT NCT05492305

    Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

    King's College London 20 participants Est. completion 2023-08 1 site
    Other conditions: Diabetes Mellitus, Obesity, Mental Health Issue
    View official trial listing →
  • Completed NCT NCT05492409

    Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

    Not yet reported AO GENERIUM 160 participants Est. completion 2024-04-03 13 sites
    Other conditions: Idiopathic Thrombocytopenic Purpura
    View official trial listing →
  • Completed NCT NCT05526157

    An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

    Bayer 50000 participants Est. completion 2024-09-05 5 sites
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT05535322

    Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity

    Ana Palanca 26944 participants Est. completion 2022-09-01 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05578352

    The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy

    Not yet reported Nanjing First Hospital, Nanjing Medical University 20 participants Est. completion 2023-01-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05583240

    Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).

    Not yet reported Etablissement Public de Santé Barthélemy Durand 50 participants Est. completion 2023-07-30 1 site
    Other conditions: Psychiatric Disorder, Benzodiazepine Withdrawal
    View official trial listing →
  • Status unknown NCT NCT05600218

    RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists

    Hospital Costa del Sol 60 participants Est. completion 2024-12-31 10 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT05629052

    TrEatment Approach in the Multimodal Era Registry

    International CTEPH Association 1000 participants Est. completion 2028-04 25 sites
    Other conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH
    View official trial listing →
  • Status unknown NCT NCT05670015

    Ocular Changes With Alpha-2 Receptor Agonist.

    Not yet reported Benha University 150 participants Est. completion 2023-09-22 1 site
    Other conditions: Glaucoma, Suspect, Aberration, Corneal Wavefront
    View official trial listing →
  • Status unknown NCT NCT05692297

    Denosumab Treatment in CKD Patients at High Risk of Fracture

    Not yet reported Capital Medical University 102 participants Est. completion 2025-12-31 1 site
    Chronic kidney disease Other conditions: Fracture, Bone Density, Low, End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT05694741

    A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

    Not yet reported AstraZeneca 31 participants Est. completion 2023-05-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT05762744

    Pharmacogenomics of GLP1 Receptor Agonists

    Not yet reported University of Maryland, Baltimore 63 participants Est. completion 2022-10-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05786521

    Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

    Not yet reported The University of Texas Health Science Center at San Antonio 20 participants Est. completion 2024-05-20 1 site
    Type 2 diabetesPrediabetes Other conditions: Aging, Overweight and Obesity
    View official trial listing →
  • Status unknown NCT NCT05818995

    Therapeutic Drug Use for CKD Patients

    Qianfoshan Hospital 10000 participants Est. completion 2024-06-30 1 site
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT05861297

    Immune Thrombocytopenia Management in Adults

    Not yet reported Nahda University 467 participants Est. completion 2024-04-02 1 site
    Other conditions: Immune Thrombocytopenia Purpura
    View official trial listing →
  • Status unknown NCT NCT05870462

    Semaglutide and Vascular Regeneration

    Not yet reported Canadian Medical and Surgical Knowledge Translation Research Group 100 participants Est. completion 2024-12 2 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Obesity
    View official trial listing →
  • Completed NCT NCT05889637

    Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

    The University of Texas Health Science Center, Houston 132 participants Est. completion 2023-07-12 1 site
    Other conditions: Pulmonary Aspiration
    View official trial listing →
  • Not yet recruiting NCT NCT05907499

    Decitabine for Poor Graft Function Post Allo-HSCT

    Not yet reported The First Affiliated Hospital of Soochow University 76 participants Est. completion 2026-11-01
    Other conditions: Poor Graft Function
    View official trial listing →
  • Completed NCT NCT05987371

    A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 75 participants Est. completion 2024-04-23 11 sites Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Status unknown NCT NCT05990374

    Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

    Not yet reported Nanjing First Hospital, Nanjing Medical University 100 participants Est. completion 2024-01-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT06009965

    Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

    Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2025-01-31 1 site
    Other conditions: Aplastic Anemia, CSA, Drug Therapy
    View official trial listing →
  • Completed NCT NCT06017544

    GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

    University of Campania Luigi Vanvitelli 257 participants Est. completion 2024-12-01 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT06055101

    Regional Anaesthesia

    Not yet reported Reham Ali Abdelhaleem Abdelrahman 54 participants Est. completion 2023-04-04 1 site
    Other conditions: Anesthesia, Obstetric
    View official trial listing →
  • Completed NCT NCT06101667

    Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)

    Not yet reported Beijing Tiantan Hospital 224 participants Est. completion 2026-07-01 1 site
    Cardiovascular disease Other conditions: Basilar Artery Occlusion
    View official trial listing →
  • Status unknown NCT NCT06110507

    Chronic Anergic-anhedonic Depression Open Trial

    University Hospital, Strasbourg, France 60 participants Est. completion 2024-03-22 1 site
    Other conditions: Depressive Disorder, Treatment-Resistant
    View official trial listing →
  • Completed NCT NCT06120556

    Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

    Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 130 participants Est. completion 2023-10-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06154486

    Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

    Hospital Israelita Albert Einstein 30 participants Est. completion 2023-08-22 1 site
    Other conditions: Pneumonia, Aspiration, Anesthesia
    View official trial listing →
  • Active, not recruiting NCT NCT06162715

    GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

    Not yet reported, Not yet reported Vanderbilt University Medical Center 30 participants Est. completion 2027-12-01 1 site
    Other conditions: Severe Obesity, Obesity, BMI Greater Than 30
    View official trial listing →
  • Completed NCT NCT06182891

    Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy

    Not yet reported The Affiliated Hospital of Xuzhou Medical University 300 participants Est. completion 2023-10-30 1 site Added to GLP-1
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT06236672

    Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

    LMC Diabetes & Endocrinology Ltd. 348 participants Est. completion 2023-11-29 1 site
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT06251375

    Early Sedation With Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients

    Not yet reported St. Joseph's Healthcare Hamilton 300 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Respiratory Insufficiency
    View official trial listing →
  • Completed NCT NCT06263595

    Semaglutide and Preoperative Residual Gastric Volumes

    University of Calgary 94 participants Est. completion 2025-05-16 1 site
    Other conditions: Pulmonary Aspiration
    View official trial listing →
  • Terminated NCT NCT06273163

    Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation

    Not yet reported University of Texas Southwestern Medical Center 39 participants Est. completion 2025-08-05 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06282458

    Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

    Not yet reported Veru Inc. 168 participants Est. completion 2025-08-22 14 sites Stand-alone
    Other conditions: Muscle Loss, Obesity
    View official trial listing →
  • Completed NCT NCT06287567

    Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 17 participants Est. completion 2025-03-06 1 site
    Other conditions: Idiopathic Thrombocytopenic Purpura, Immune Thrombocytopenia
    View official trial listing →
  • Status unknown NCT NCT06344247

    Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

    Not yet reported RenJi Hospital 48 participants Est. completion 2025-12-01 1 site
    Chronic kidney disease Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06355219

    Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines

    Ali Aminian 3932 participants Est. completion 2024-05-20
    Type 2 diabetesHeart failure Other conditions: Obesity, Microvascular Disease, Macrovascular Disease, Major Adverse Cardiovascular Events, Nephropathy, Retinopathy, All Cause Mortality
    View official trial listing →
  • Completed NCT NCT06359314

    Anxiety Lowering and Deprescribing Through Emotion Regulation

    Not yet reported Northwestern University 33 participants Est. completion 2024-09-10 1 site
    Other conditions: Benzodiazepine Dependence, Anxiety Disorders, Sleep Disturbance
    View official trial listing →
  • Status unknown NCT NCT06365190

    Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease

    Not yet reported Anhui Medical University 47 participants Est. completion 2024-07-31 1 site
    Other conditions: Transcranial Magnetic Stimulation, Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT06388213

    Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

    University Hospital, Geneva 40 participants Est. completion 2026-05
    Type 2 diabetes Other conditions: Anesthesia, Pulmonary Aspiration of Gastric Contents
    View official trial listing →
  • Completed NCT NCT06408324

    Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

    European Research Consortium on ITP 275 participants Est. completion 2024-04-05 17 sites
    Other conditions: Primary Immune Thrombocytopenia (ITP)
    View official trial listing →
  • Status unknown NCT NCT06449235

    Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

    Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 site
    Other conditions: Type2diabetes
    View official trial listing →
  • Completed NCT NCT06458400

    To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain

    Not yet reported Yuwei Qiu 75 participants Est. completion 2024-10-06 1 site
    Other conditions: Analgesia
    View official trial listing →
  • Not yet recruiting NCT NCT06474286

    Prucalopride for Cognitive Functioning in Schizophrenia

    Not yet reported University of Pittsburgh 34 participants Est. completion 2026-12-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT06481085

    To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 324 participants Est. completion 2025-06-30 31 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06500143

    Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery

    Ciusss de L'Est de l'Île de Montréal 94 participants Est. completion 2025-02-28 1 site
    Other conditions: Gastric Retention
    View official trial listing →
  • Status unknown NCT NCT06500299

    Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180 participants Est. completion 2024-11-30
    Other conditions: Overweight and Obesity
    View official trial listing →
  • Status unknown NCT NCT06520540

    HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72 participants Est. completion 2024-12-30 1 site
    Other conditions: Glucagon-Like Peptide-1 Receptor Agonists
    View official trial listing →
  • Not yet recruiting NCT NCT06546384

    GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease

    Not yet reported Insel Gruppe AG, University Hospital Bern 64 participants Est. completion 2027-04-30 1 site
    Alcohol use disorder Other conditions: Adiposity, Fatty Liver
    View official trial listing →
  • Status unknown NCT NCT06562088

    A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 40 participants Est. completion 2024-12-30 1 site
    Other conditions: Healthy Adult Subject
    View official trial listing →
  • Status unknown NCT NCT06568913

    The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

    Not yet reported Sohag University 100 participants Est. completion 2025-07-14 1 site Stand-alone
    Other conditions: Persistent or Chronic ITP Not Respnding to Steroids
    View official trial listing →
  • Enrolling by invitation NCT NCT06581120

    GLP_1 RA Ultrasound Study

    Children's Hospital Medical Center, Cincinnati 100 participants Est. completion 2026-07 1 site
    Other conditions: Glucagon Like Peptide-1 (GLP-1, Delayed Gastric Emptying, Risk of Aspiration, Diabetes, Morbid Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT06601517

    A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 30 participants Est. completion 2025-04 1 site
    Other conditions: Healthy Adult Subject, Overweight Subject
    View official trial listing →
  • Not yet recruiting NCT NCT06608329

    A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 33 participants Est. completion 2024-12 1 site
    Other conditions: Healthy Adult Subject
    View official trial listing →
  • Completed NCT NCT06608433

    Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

    Not yet reported University Hospital, Basel, Switzerland 22 participants Est. completion 2025-11-30 1 site
    Other conditions: Healthy Volunteer Study, HPA, Cortisol Deficiency, Adrenal Insufficiency
    View official trial listing →
  • Completed NCT NCT06634927

    Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68 participants Est. completion 2025-02-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06660134

    Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

    Not yet reported Shanghai Chest Hospital 174 participants Est. completion 2024-01-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Not yet recruiting NCT NCT06729320

    A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

    Not yet reported Beijing GoBroad Hospital 40 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Refractory Immune Effector Cell-related Hemocytopenia
    View official trial listing →
  • Completed NCT NCT06738082

    Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

    Insel Gruppe AG, University Hospital Bern 147 participants Est. completion 2025-01-31 1 site
    Other conditions: Influenza Vaccine, Immunocompromised Patients
    View official trial listing →
  • Completed NCT NCT06739044

    Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 494 participants Est. completion 2025-02-21 1 site
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT06745219

    Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

    Not yet reported Peking University Cancer Hospital & Institute 30 participants Est. completion 2025-07-30 1 site
    Other conditions: Thrombopenia, Cervical Cancer, Radiotherapy Side Effect, Chemotherapeutic Toxicity
    View official trial listing →
  • Not yet recruiting NCT NCT06775093

    Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

    Not yet reported Peking University Third Hospital 392 participants Est. completion 2027-12-31 1 site
    Other conditions: Polycystic Ovary Syndrome, Obesity, Infertility, Female
    View official trial listing →
  • Active, not recruiting NCT NCT06807970

    Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist

    Not yet reported The University of Hong Kong 54 participants Est. completion 2028-07-01 1 site Added to GLP-1
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT06850129

    Efficacy of a Digital Educational Intervention in Patients With Type 2 Diabetes Mellitus

    Not yet reported HOSPITAL VITHAS SEVILLA 85 participants Est. completion 2023-10-26 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT06873672

    Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

    RenJi Hospital 360 participants Est. completion 2027-12-31 1 site
    Other conditions: Quality of Life (QOL), Patient-Reported Outcome Measures (PROMs), Pneumonia Childhood, Neuroblastoma (NB), Wilms Tumour, Immune Thrombocytopenic Purpura ( ITP )
    View official trial listing →
  • Completed NCT NCT06981936

    This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control

    Not yet reported General Committee of Teaching Hospitals and Institutes, Egypt 150 participants Est. completion 2026-05-29 1 site
    Other conditions: Micronutrient Deficiencies
    View official trial listing →
  • Not yet recruiting NCT NCT07014709

    Impact of GLP-1 Receptor Agonists on Patients With IPMN

    Hôpital Fribourgeois 30 participants Est. completion 2026-10-31 1 site
    Other conditions: IPMN, IPMN, Pancreatic, GLP-1, Intraductal Papillary Mucinous Neoplasm of Pancreas, Glucagon-Like Peptide-1 Receptor Agonists
    View official trial listing →
  • Not yet recruiting NCT NCT07021937

    Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

    Not yet reported University of Colorado, Denver 120 participants Est. completion 2031-04-30 1 site
    Other conditions: Obesity/Therapy
    View official trial listing →
  • Enrolling by invitation NCT NCT07034898

    Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients

    Not yet reported Ain Shams University 60 participants Est. completion 2025-08-31 1 site
    Other conditions: Airway Stress Response
    View official trial listing →
  • Active, not recruiting NCT NCT07055386

    A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

    Not yet reported Gan & Lee Pharmaceuticals. 90 participants Est. completion 2027-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07073053

    The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

    Not yet reported Taipei Veterans General Hospital, Taiwan 60 participants Est. completion 2028-07-31 1 site
    Type 2 diabetes Other conditions: Glucagon-Like Peptide-1 Receptor Agonists, Coronary Arterial Disease (CAD)
    View official trial listing →
  • Enrolling by invitation NCT NCT07092605

    Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

    Not yet reported AgelessRx 150 participants Est. completion 2025-12-01 1 site
    Other conditions: Longevity, Quality of Life, Mood, Inflammation, Immune Health, Pain Management, Weight Management, Alertness
    View official trial listing →
  • Not yet recruiting NCT NCT07100691

    Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

    Not yet reported Mater Misericordiae University Hospital 80 participants Est. completion 2026-06 2 sites Stand-alone
    Other conditions: Pulmonary Aspiration During Anaesthetic Induction, Gastric Emptying Time, Preoperative Risk Assessment, Obesity (Disorder)
    View official trial listing →
  • Active, not recruiting NCT NCT07115069

    Comparison of Body Composition Changes With Weight Loss Interventions

    Vanderbilt University Medical Center 60 participants Est. completion 2027-12 1 site
    Other conditions: Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07130396

    Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

    Not yet reported Metagenics, Inc. 100 participants Est. completion 2026-04-30
    Other conditions: GLP-1, Adults
    View official trial listing →
  • Enrolling by invitation NCT NCT07140289

    Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

    Wael Saasouh, MD 100 participants Est. completion 2028-06-01 1 site
    Other conditions: Gastric Emptying, Glucagon-Like Peptide-1 Receptor Agonists, Intermittent Fasting, Intraoperative Complication Due to Anesthesia, Respiratory Aspiration of Gastric Contents
    View official trial listing →
  • Not yet recruiting NCT NCT07179120

    Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health

    Not yet reported First Affiliated Hospital of Wenzhou Medical University 180 participants Est. completion 2027-01-02
    Other conditions: Obesity-related Male Infertility
    View official trial listing →
  • Terminated NCT NCT07190794

    RESCUE: Discontinuation of GLP-1

    Boston Scientific Corporation 18 participants Est. completion 2026-05-26 1 site
    Other conditions: Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07251556

    GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

    Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2027-01-01
    Other conditions: Psoriasis Arthritis
    View official trial listing →
  • Completed NCT NCT07269821

    Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

    Not yet reported University of Alicante 70 participants Est. completion 2025-11-30 1 site
    Other conditions: GLP-1, Weight Loss Trajectory, Emotional Disorder, Microbiota Balance
    View official trial listing →
  • Not yet recruiting NCT NCT07276763

    Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

    Fudan University 16509 participants Est. completion 2025-12-15 1 site
    Other conditions: Gastric Retention
    View official trial listing →
  • Completed NCT NCT07297238

    Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

    Not yet reported Jinling Hospital, China 20 participants Est. completion 2026-06-30 2 sites Stand-alone
    Other conditions: Short Bowel Syndrome (SBS), Intestinal Failure
    View official trial listing →
  • Active, not recruiting NCT NCT07303556

    Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs

    Not yet reported Nazarbayev University 120 participants Est. completion 2026-11-01 1 site Added to GLP-1
    Heart failure Other conditions: Diabete Type 2, Arterial Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07314528

    Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

    Not yet reported St. James's Hospital, Ireland 42 participants Est. completion 2028-09
    Other conditions: Rectal Cancer Patients, Obesity &Amp; Overweight, Locally Advanced Rectal Cancer (LARC), Total Neoadjuvant Therapy, GLP-1
    View official trial listing →
  • Enrolling by invitation NCT NCT07319286

    Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Ain Shams University 50 participants Est. completion 2027-03 2 sites
    Other conditions: Menstrual Irregularities, Type1 Diabetes Mellitus, Glucagon-Like Peptide-1 Receptor Agonists, Female Reproductive Health
    View official trial listing →
  • Active, not recruiting NCT NCT07325435

    Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

    Not yet reported MaryAnn Banerji 60 participants Est. completion 2028-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT07348718

    Rubix LS Diabetic Kidney Disease (DKD) Registry Study

    Rubix LS 2000 participants Est. completion 2026-04-01 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT07360262

    Gastric Emptying Recovery After GLP-1 RA Cessation

    Wonkwang University Hospital 186 participants Est. completion 2026-01-12 2 sites
    Other conditions: Gastric Emptying, Gastroparesis, Preoperative Care
    View official trial listing →
  • Completed NCT NCT07374445

    Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100 participants Est. completion 2025-06-01 1 site
    Other conditions: Obesity, Weight Loss, Bariatric Surgery
    View official trial listing →
  • Not yet recruiting NCT NCT07391267

    Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

    Not yet reported Institute of Liver and Biliary Sciences, India 90 participants Est. completion 2028-12-31 1 site Added to GLP-1
    Chronic kidney disease Other conditions: MAFLD
    View official trial listing →
  • Not yet recruiting NCT NCT07403032

    Study on the Effects and Mechanisms of Modified Ma Xing Shi Gan Decoction in Treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease

    Not yet reported Cuiling Feng 200 participants Est. completion 2028-06-30 Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT07437716

    Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years

    Not yet reported Kafrelsheikh University 60 participants Est. completion 2025-09-01 1 site Stand-alone
    Type 2 diabetesObstructive sleep apnea Other conditions: Laparascopic Sleeve Gastrectomy, Obesity & Overweight, Hypertension (HTN), Osteo Arthritis of the Knee
    View official trial listing →
  • Completed NCT NCT07455630

    Cardiac Function and Biomarkers in Patients With Obesity and Overweight

    TecSalud Investigación Clínica 30 participants Est. completion 2024-09-30 1 site
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT07457424

    Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

    University College Dublin 140 participants Est. completion 2027-01-31 1 site
    Other conditions: Metabolic Disease, Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07511543

    Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

    Not yet reported Population Health Research Institute 826 participants Est. completion 2031-12-30
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07539584

    Adiponectin in Patients With Metabolic Disorders

    Not yet reported Moscow Regional Research and Clinical Institute (MONIKI) 130 participants Est. completion 2024-04-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
    View official trial listing →
  • Not yet recruiting NCT NCT07567495

    Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery

    Not yet reported Columbia University 150 participants Est. completion 2028-05 1 site
    Other conditions: Cesarean Delivery, Cesarean Delivery; Neuraxial Opioids, Spinal Anesthesia for Cesarean Section, Dexmedetomidine, Clonidine, Postoperative Analgesia
    View official trial listing →
  • Not yet recruiting NCT NCT07600723

    A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

    Not yet reported Merck Sharp & Dohme LLC 30 participants Est. completion 2028-04-03 Stand-alone
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07605390

    RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

    Not yet reported Baylor Research Institute 600 participants Est. completion 2028-01 2 sites
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT07610174

    Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves

    Not yet reported Kafrelsheikh University 160 participants Est. completion 2026-04-29 1 site
    Heart failure Other conditions: Heart Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT07611201

    The Effects of GLP-1 Receptor Agonists on Chemosensory Function and Ingestive Behavior

    Purdue University 90 participants Est. completion 2026-05-04 1 site Stand-alone
    Other conditions: Obesity, Overweight, Taste Perception, Olfaction, Eating Behavior, Appetite
    View official trial listing →
  • Not yet recruiting NCT NCT07611552

    Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss

    Not yet reported Huazhong University of Science and Technology 600 participants Est. completion 2026-11 5 sites
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Completed NCT NCT07623148

    GLP-1 RA Cessation and Gastric Ultrasound Findings

    Wonkwang University Hospital 186 participants Est. completion 2026-08-04 1 site
    Other conditions: Residual Gastric Contents, Delayed Gastric Emptying
    View official trial listing →
  • Not yet recruiting NCT NCT07627191

    GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

    Not yet reported University of Arizona 30 participants Est. completion 2028-06-30 1 site
    Other conditions: Pancreatic Cancer, Colorectal Cancer, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT07628556

    Antidiabetic Medications and Risk of Cancer

    University of Pecs 74799 participants Est. completion 2025-12-30 1 site
    Other conditions: Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07629128

    Patients With Primary Biliary Cholangitis(PBC)

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30 participants Est. completion 2027-11 1 site
    Other conditions: Primary Biliary Cholangitis, Liver Fibrosis, Cirrhosis, Liver, Blood Sugar; High
    View official trial listing →
  • Suspended NCT NCT07633314

    A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90 participants Est. completion 2027-01 16 sites Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07642635

    Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

    Not yet reported, Not yet reported Vanderbilt University Medical Center 30 participants Est. completion 2030-12 1 site
    Other conditions: Duchenne Muscular Dystrophy (DMD)
    View official trial listing →
  • Not yet recruiting NCT NCT07668765

    GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity

    Gazi University 100 participants Est. completion 2027-05 1 site
    Other conditions: Morbid Obesity, Anorectal Diseases, Drug-Related Side Effects and Adverse Reactions, Constipation, Diarrhea
    View official trial listing →
  • Not yet recruiting NCT NCT07676331

    Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

    Not yet reported Universitaire Ziekenhuizen KU Leuven 168 participants Est. completion 2028-05-01
    Other conditions: Hormone-receptor-positive Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT07677865

    GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

    West China Hospital 213891 participants Est. completion 2026-06-24 1 site
    Type 2 diabetes Other conditions: Alzheimer Disease, Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07687667

    Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

    Not yet reported Peking University Third Hospital 406 participants Est. completion 2029-12 1 site
    Other conditions: Polycystic Ovary Syndrome (PCOS), Obesity, Infertility, Female
    View official trial listing →
  • Not yet recruiting NCT NCT07701460

    Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1

    Not yet reported Tufts University 200 participants Est. completion 2028-07-31 1 site
    Other conditions: Weight Maintenance
    View official trial listing →
  • Not yet recruiting NCT NCT07723820

    Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

    Thammasat University Hospital 126 participants Est. completion 2027-09-01 1 site
    Type 2 diabetes Other conditions: Diabetic Retinopathy (DR)
    View official trial listing →
  • Not yet recruiting NCT NCT07728812

    Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy

    Not yet reported Phenomix Sciences 424 participants Est. completion 2029-01-01 Stand-alone
    Other conditions: Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07755085

    GLP-1s in Hip and Knee Arthroplasty

    Not yet reported Nova Scotia Health Authority 100 participants Est. completion 2028-12 1 site Added to GLP-1
    Other conditions: Arthritis, Obesity & Overweight, GLP - 1
    View official trial listing →
  • Not yet recruiting NCT NCT07760532

    Comparing Facial Aging Between Identical Twins With 3D Imaging

    Ponsky Facial Aesthetics And Plastic Surgery, Llc 200 participants Est. completion 2026-09 1 site
    Other conditions: Facial Skin Aging, Facial Volume Loss, Wrinkle Appearance
    View official trial listing →
  • Not yet recruiting NCT NCT07770737

    Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes

    Dongtan Sacred Heart Hospital 100 participants Est. completion 2027-12-31 1 site
    Type 2 diabetesCardiovascular diseaseHeart failure
    View official trial listing →
  • Not yet recruiting NCT NCT07770906

    Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy

    Not yet reported Cukurova University 40 participants Est. completion 2027-12-01
    Other conditions: Periodontal Disease, Obesity & Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07773532

    Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder

    Bagcilar Training and Research Hospital 115 participants Est. completion 2027-11-01 1 site
    Other conditions: Overactive Bladder (OAB)
    View official trial listing →
  • Not yet recruiting NCT NCT07775846

    QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

    Not yet reported Huijie Zhang 820 participants Est. completion 2029-06-30 1 site
    Chronic kidney disease
    View official trial listing →
  • Not yet recruiting NCT NCT07783113

    Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

    Not yet reported Farmoquimica S.A. 48 participants Est. completion 2027-02 1 site
    Other conditions: Alopecia
    View official trial listing →
  • Not yet recruiting NCT NCT07787936

    GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

    Miedziowe Centrum Zdrowia SA 150 participants Est. completion 2033-01-01 1 site
    Heart failure Other conditions: Obesity, Pulmonary Hypertension, Iron Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07789223

    Weight and Metabolic Management Study

    Not yet reported Elenzia 200 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Overweight, Obesity, Weight Maintenance
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Receptor Agonists, Receptor Agonists (GLP1RA)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.